Cytosole-CEA-measurement as predictative test in carcinoma, particularly mammacarcinoma.

摘要

The usefulness of the carcino-embryonic-antigen (CEA) as tumor-marker is tested at the time of primary therapy or at the time of a regression by determining the CEA content quantitatively in the cytosole or tissue of the tumor. Preferably the cytosole is used which is obtained from the tumor for the hormone receptor analysis.